AGRN
AGRN (agrin, also written AGRIN and previously named agrin proteoglycan) is a multi-domain proteoglycan that is critical for development of the neuromuscular junction. It is found in the extracellular matrix, at synapses and at the cell membrane. Browse Assay Genie's current range of AGRN research reagents below, or read on for the biology behind the target.
AGRN encodes agrin, one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. Agrin signalling is central to this role. A fragment released from the full-length protein is important for agrin signalling and exerts a maximal dendritic filopodia-inducing effect. All 'z' splice variants (z+) of this fragment also increase the number of filopodia.
The agrin protein contains several laminin G domains, Kazal-type serine protease inhibitor domains and epidermal growth factor domains. Further post-translational modifications add glycosaminoglycans and disulfide bonds, consistent with its classification in the HGNC gene group of proteoglycans that contain SEA domains. UniProt records agrin as secreted into the extracellular space and extracellular matrix, and also at the synapse and the cell membrane. Alternative splicing of the AGRN gene produces multiple transcript variants that encode different isoforms, including the 'z' variants noted above.
AGRN is also linked to disease. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found. This connection to neuromuscular transmission makes the agrin protein a frequent subject in studies of synapse formation and muscle disorders. Mouse and rat both have an orthologous gene, Agrn.
Agrin is critical for NMJ development, as identified in mouse knock-out studies, making AGRN a core target in synapse formation research.
A mutation in AGRN was found in one family with congenital myasthenic syndrome affecting limb-girdle muscles.
A released agrin fragment supports agrin signalling and induces dendritic filopodia, with z+ splice variants increasing filopodia number.
Agrin carries glycosaminoglycans and several laminin G, Kazal and EGF-type domains, making it a model multi-domain matrix proteoglycan.
AGRN encodes agrin, a protein critical for development of the neuromuscular junction, as shown in mouse knock-out studies. A released fragment is important for agrin signalling and for inducing dendritic filopodia. Check the datasheet of any product for its validated reactivity.
AGRN is also written AGRIN, and its previous name was agrin proteoglycan. Alternative splicing gives multiple transcript variants that encode different isoforms, including 'z' splice variants (z+) whose fragment increases the number of filopodia.
Mouse and rat each have an orthologous gene named Agrn, and mouse knock-out studies helped identify its role at the neuromuscular junction. In humans, a mutation was found in one family with limb-girdle congenital myasthenic syndrome.
Other neuromuscular junction, synaptic and extracellular matrix proteins with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00468; product specifications from Assay Genie datasheets.